Sarcomas of the head and neck in adult patients: current concepts and future perspectives

References

• Tran LM, Mark R, Meier R, Calcaterra TC, Parker RG. Sarcomas of the head and neck. Prognostic factors and treatment strategies. Cancer70(1), 169–177 (1992).
   PubMed Web of Science ®Google Scholar
• Lyos AT, Goepfert H, Luna MA, Jaffe N, Malpica A. Soft tissue sarcoma of the head and neck in children and adolescents. Cancer77(1), 193–200 (1996).
   Google Scholar
• Toro JR, Travis LB, Wu HJ et al. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: an analysis of 26,758 cases. Int. J. Cancer119(12), 2922–2930 (2006).
   PubMed Web of Science ®Google Scholar
• Clark MA, Fisher C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. N. Engl. J. Med.353(7), 701–711 (2005).
   PubMed Web of Science ®Google Scholar
• Fernandez Sanroman J, Alonso del Hoyo JR, Diaz FJ et al. Sarcomas of the head and neck. Br. J. Oral Maxillofac. Surg.30(2), 115–118 (1992).
   Google Scholar
• Leinung S, Mobius C, Udelnow A, Hauss J, Wurl P. Histopathological outcome of 597 isolated soft tissue tumors suspected of soft tissue sarcoma: a single-center 12-year experience. Eur. J. Surg. Oncol.33(4), 508–511 (2007).
   Google Scholar
• Deyrup AT, Weiss SW. Grading of soft tissue sarcomas: the challenge of providing precise information in an imprecise world. Histopathology48(1), 42–50 (2006).
   PubMed Web of Science ®Google Scholar
• Gorsky M, Epstein JB. Head and neck and intra-oral soft tissue sarcomas. Oral Oncol.34(4), 292–296 (1998).
   Web of Science ®Google Scholar
• Hogendoorn PC, Collin F, Daugaard S et al. Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment. Eur. J. Cancer40(11), 1644–1654 (2004).
   PubMed Web of Science ®Google Scholar
• Pandey M, Chandramohan K, Thomas G et al. Soft tissue sarcoma of the head and neck region in adults. Int. J. Oral Maxillofac. Surg.32(1), 43–48 (2003).
   Google Scholar
• Mendenhall WM, Mendenhall CM, Werning JW, Riggs CE, Mendenhall NP. Adult head and neck soft tissue sarcomas. Head Neck27(10), 916–922 (2005).
   Web of Science ®Google Scholar
• Kotilingam D, Lev DC, Lazar AJ, Pollock RE. Staging soft tissue sarcoma: evolution and change. CA Cancer J. Clin.56(5), 282–291; quiz 314–285 (2006).
   PubMed Web of Science ®Google Scholar
• Daugaard S. Current soft-tissue sarcoma classifications. Eur. J. Cancer40(4), 543–548 (2004).
   PubMed Web of Science ®Google Scholar
• Stiller CA, Bielack SS, Jundt G, Steliarova-Foucher E. Bone tumours in European children and adolescents, 1978–1997. Report from the Automated Childhood Cancer Information System project. Eur. J. Cancer42(13), 2124–2135 (2006).
   PubMed Web of Science ®Google Scholar
• Borden EC, Baker LH, Bell RS et al. Soft tissue sarcomas of adults: state of the translational science. Clin. Cancer Res.9(6), 1941–1956 (2003).
   PubMed Web of Science ®Google Scholar
• Barr FG, Zhang PJ. The impact of genetics on sarcoma diagnosis: an evolving science. Clin. Cancer Res.12(18), 5256–5257 (2006).
   PubMedGoogle Scholar
• Segal NH, Pavlidis P, Antonescu CR et al. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am. J. Pathol.163(2), 691–700 (2003).
   PubMed Web of Science ®Google Scholar
• Fletcher CD. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology48(1), 3–12 (2006).
   PubMed Web of Science ®Google Scholar
• Mertens F, Stromberg U, Rydholm A et al. Prognostic significance of chromosome aberrations in high-grade soft tissue sarcomas. J. Clin. Oncol.24(2), 315–320 (2006).
   PubMed Web of Science ®Google Scholar
• Suehara Y, Kondo T, Fujii K et al. Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas. Proteomics6(15), 4402–4409 (2006).
   PubMed Web of Science ®Google Scholar
• Antonescu CR. The role of genetic testing in soft tissue sarcoma. Histopathology48(1), 13–21 (2006).
   PubMed Web of Science ®Google Scholar
• Glenn J, Kinsella T, Glatstein E et al. A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk. Cancer55(6), 1206–1214 (1985).
   PubMed Web of Science ®Google Scholar
• Pollock RE, Karnell LH, Menck HR, Winchester DP. The National Cancer Data Base report on soft tissue sarcoma. Cancer78(10), 2247–2257 (1996).
   PubMed Web of Science ®Google Scholar
• Figueiredo MT, Marques LA, Campos-Filho N. Soft-tissue sarcomas of the head and neck in adults and children: experience at a single institution with a review of literature. Int. J. Cancer41(2), 198–200 (1988).
   Google Scholar
• Kraus DH, Dubner S, Harrison LB et al. Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer74(2), 697–702 (1994).
   Google Scholar
• Mark RJ, Bailet JW, Poen J et al. Postirradiation sarcoma of the head and neck. Cancer72(3), 887–893 (1993).
   Google Scholar
• Mark RJ, Poen J, Tran LM et al. Postirradiation sarcomas. A single-institution study and review of the literature. Cancer73(10), 2653–2662 (1994).
   PubMed Web of Science ®Google Scholar
• Callender TA, Weber RS, Janjan N et al. Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol. Head Neck Surg.112(2), 252–257 (1995).
   PubMed Web of Science ®Google Scholar
• Little DJ, Ballo MT, Zagars GK et al. Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer95(2), 377–388 (2002).
   PubMed Web of Science ®Google Scholar
• Rapidis AD, Gakiopoulou H, Stavrianos SD et al. Sarcomas of the head and neck. Results from the treatment of 25 patients. Eur. J. Surg. Oncol.31(2), 177–182 (2005).
   Google Scholar
• Daskalopoulou D, Rapidis AD, Maounis N, Markidou S. Fine-needle aspiration cytology in tumors and tumor-like conditions of the oral and maxillofacial region: diagnostic reliability and limitations. Cancer81(4), 238–252 (1997).
   Web of Science ®Google Scholar
• Fleshman R, Mayerson J, Wakely PE Jr. Fine-needle aspiration biopsy of high-grade sarcoma: a report of 107 cases. Cancer111(6), 491–498 (2007).
   Google Scholar
• Huber GF, Matthews TW, Dort JC. Soft-tissue sarcomas of the head and neck: a retrospective analysis of the Alberta experience 1974 to 1999. Laryngoscope116(5), 780–785 (2006).
   Google Scholar
• Takahama A Jr, Nascimento AG, Brum MC, Vargas PA, Lopes MA. Low-grade myofibroblastic sarcoma of the parapharyngeal space. Int. J. Oral Maxillofac. Surg.35(10), 965–968 (2006).
   Google Scholar
• Frankenthaler R, Ayala AG, Hartwick RW, Goepfert H. Fibrosarcoma of the head and neck. Laryngoscope100(8), 799–802 (1990).
   PubMed Web of Science ®Google Scholar
• Leitner C, Hoffmann J, Krober S, Reinert S. Low-grade malignant fibrosarcoma of the dental follicle of an unerupted third molar without clinical evidence of any follicular lesion. J. Craniomaxillofac. Surg.35(1), 48–51 (2007).
   Google Scholar
• Jay A, Piper K, Farthing PM, Carter J, Diwakar A. Low-grade myofibroblastic sarcoma of the tongue. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.104(5), e52–e58 (2007).
   Google Scholar
• Nishimura G, Sano D, Hanashi M et al. Myxofibrosarcoma of the hypopharynx. Auris Nasus Larynx33(1), 93–96 (2006).
   Google Scholar
• Panagopoulos I, Storlazzi CT, Fletcher CD et al. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer40(3), 218–228 (2004).
   PubMed Web of Science ®Google Scholar
• Antonescu CR, Baren A. Spectrum of low-grade fibrosarcomas: a comparative ultrastructural analysis of low-grade myxofibrosarcoma and fibromyxoid sarcoma. Ultrastruct. Pathol.28(5–6), 321–332 (2004).
   PubMed Web of Science ®Google Scholar
• Coyne JD. Low-grade myofibroblastic sarcoma of the piriform fossa: a case report with a literature review of a tumour with a predilection for the head and neck. Br. J. Oral Maxillofac. Surg.45(4), 335–337 (2007).
   Google Scholar
• Hansen T, Katenkamp K, Brodhun M, Katenkamp D. Low-grade fibrosarcoma – report on 39 not otherwise specified cases and comparison with defined low-grade fibrosarcoma types. Histopathology49(2), 152–160 (2006).
   PubMedGoogle Scholar
• Meng GZ, Zhang HY, Bu H et al. Myofibroblastic sarcoma of the nasal cavity and paranasal sinus: a clinicopathologic study of 6 cases and review of the literature. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.104(4), 530–539 (2007).
   Google Scholar
• Sohail D, Kerr R, Simpson RH, Babajews AV. Malignant fibrous histiocytoma of the mandible: the importance of an accurate histopathological diagnosis. Br. J. Oral Maxillofac. Surg.33(3), 166–168 (1995).
   Google Scholar
• Brooks JJ. The significance of double phenotypic patterns and markers in human sarcomas. A new model of mesenchymal differentiation. Am. J. Pathol.125(1), 113–123 (1986).
   PubMed Web of Science ®Google Scholar
• Dehner LP. Malignant fibrous histiocytoma. Nonspecific morphologic pattern, specific pathologic entity, or both? Arch. Pathol. Lab. Med.112(3), 236–237 (1988).
   PubMedGoogle Scholar
• Nascimento AF, Raut CP. Diagnosis and management of pleomorphic sarcomas (so-called “MFH”) in adults. J. Surg. Oncol.97(4), 330–339 (2008).
   Google Scholar
• Fletcher CD. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am. J. Surg. Pathol.16(3), 213–228 (1992).
   PubMed Web of Science ®Google Scholar
• Fletcher CD, Gustafson P, Rydholm A, Willen H, Akerman M. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J. Clin. Oncol.19(12), 3045–3050 (2001).
   PubMed Web of Science ®Google Scholar
• Oda Y, Tamiya S, Oshiro Y et al. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts. Pathol. Int.52(9), 595–606 (2002).
   Google Scholar
• Coindre JM, Mariani O, Chibon F et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod. Pathol.16(3), 256–262 (2003).
   PubMedGoogle Scholar
• Fletcher CDM, Unni KK, Mertens F. Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press, Lyon, France (2002).
   Google Scholar
• Barnes L, Eveson JW, Reichart P, Sidransky D. Pathology and Genetics of Head and Neck Tumors. IARC Press, Lyon, France (2005).
   Google Scholar
• Muller-Richter UD, Kohlhof JK, Reichert TE, Roldan JC. Undifferentiated pleomorphic sarcoma of the orbital region. Br. J. Oral Maxillofac. Surg.46(4), 325–327 (2007).
   Google Scholar
• Erlandson RA, Antonescu CR. The rise and fall of malignant fibrous histiocytoma. Ultrastruct. Pathol.28(5–6), 283–289 (2004).
   PubMed Web of Science ®Google Scholar
• Scapolan M, Perin T, Wassermann B et al. Expression profiles in malignant fibrous histiocytomas: clues for differentiating ‘spindle cell’ and ‘pleomorphic’ subtypes. Eur. J. Cancer44(2), 298–309 (2008).
   Google Scholar
• Nagano H, Deguchi K, Kurono Y. Malignant fibrous histiocytoma of the bucca: a case report. Auris Nasus Larynx35(1), 165–169 (2008).
   Google Scholar
• Fleury RN, Damante JH, Soares CT et al. Malignant fibrous histiocytoma (undifferentiated high-grade pleomorphic sarcoma) occurring in tuberous sclerosis: a case report. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.103(4), e54–e59 (2007).
   Google Scholar
• Kanazawa H, Watanabe T, Kasamatsu A. Primary malignant fibrous histiocytoma of the mandible: review of literature and report of a case. J. Oral Maxillofac. Surg.61(10), 1224–1227 (2003).
   Google Scholar
• Singh B, Shaha A, Har-El G. Malignant fibrous histiocytoma of the head and neck. J. Craniomaxillofac. Surg.21(6), 262–265 (1993).
   Google Scholar
• Rapidis AD, Andressakis DD, Lagogiannis GA, Douzinas EE. Malignant fibrous histiocytoma of the tongue: review of the literature and report of a case. J. Oral Maxillofac. Surg.63(4), 546–550 (2005).
   Google Scholar
• Hafner HM, Moehrle M, Eder S et al. 3D-histological evaluation of surgery in dermatofibrosarcoma protuberans and malignant fibrous histiocytoma: differences in growth patterns and outcome. Eur. J. Surg. Oncol. (2007).
   Google Scholar
• Huvos AG, Heilweil M, Bretsky SS. The pathology of malignant fibrous histiocytoma of bone. A study of 130 patients. Am. J. Surg. Pathol.9(12), 853–871 (1985).
   PubMed Web of Science ®Google Scholar
• Kariya S, Aoji K, Kuyama K et al. Malignant fibrous histiocytoma of the parotid gland. Auris Nasus Larynx30(3), 315–318 (2003).
   Google Scholar
• Sabesan T, Xuexi W, Yongfa Q, Pingzhang T, Ilankovan V. Malignant fibrous histiocytoma: outcome of tumours in the head and neck compared with those in the trunk and extremities. Br. J. Oral Maxillofac. Surg.44(3), 209–212 (2006).
   Google Scholar
• Barnes L, Kanbour A. Malignant fibrous histiocytoma of the head and neck. A report of 12 cases. Arch. Otolaryngol. Head Neck Surg.114(10), 1149–1156 (1988).
   PubMedGoogle Scholar
• Schenberg ME, Slootweg PJ, Koole R. Leiomyosarcomas of the oral cavity. Report of four cases and review of the literature. J. Craniomaxillofac. Surg.21(8), 342–347 (1993).
   Google Scholar
• Sumida T, Hamakawa H, Otsuka K, Tanioka H. Leiomyosarcoma of the maxillary sinus with cervical lymph node metastasis. J. Oral Maxillofac. Surg.59(5), 568–571 (2001).
   Google Scholar
• Vilos GA, Rapidis AD, Lagogiannis GD, Apostolidis C. Leiomyosarcomas of the oral tissues: clinicopathologic analysis of 50 cases. J. Oral Maxillofac. Surg.63(10), 1461–1477 (2005).
   Google Scholar
• Dry SM, Jorgensen JL, Fletcher CD. Leiomyosarcomas of the oral cavity: an unusual topographic subset easily mistaken for nonmesenchymal tumours. Histopathology36(3), 210–220 (2000).
   Google Scholar
• Nikitakis NG, Lopes MA, Bailey JS et al. Oral leiomyosarcoma: review of the literature and report of two cases with assessment of the prognostic and diagnostic significance of immunohistochemical and molecular markers. Oral Oncol.38(2), 201–208 (2002).
   Google Scholar
• Rodini CO, Pontes FS, Pontes HA et al. Oral leiomyosarcomas: report of two cases with immunohistochemical profile. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.104(4), e50–e55 (2007).
   Google Scholar
• Bucci T, Longo F, Mangone GM, Errico ME, Califano L. Leiomyosarcoma of the submandibular gland. Report of a case and review of the literature. Int. J. Oral Maxillofac. Surg.34(6), 690–692 (2005).
   Google Scholar
• Akcam T, Oysul K, Birkent H, Gerek M, Yetiser S. Leiomyosarcoma of the head and neck: report of two cases and review of the literature. Auris Nasus Larynx32(2), 209–212 (2005).
   Google Scholar
• Svarvar C, Bohling T, Berlin O et al. Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group. Cancer109(2), 282–291 (2007).
   PubMed Web of Science ®Google Scholar
• Ethunandan M, Stokes C, Higgins B et al. Primary oral leiomyosarcoma: a clinico-pathologic study and analysis of prognostic factors. Int. J. Oral Maxillofac. Surg.36(5), 409–416 (2007).
   Google Scholar
• Estilo CL, Huryn JM, Kraus DH et al. Effects of therapy on dentofacial development in long-term survivors of head and neck rhabdomyosarcoma: the memorial sloan-kettering cancer center experience. J. Pediatr. Hematol. Oncol.25(3), 215–222 (2003).
   Google Scholar
• Chigurupati R, Alfatooni A, Myall RW, Hawkins D, Oda D. Orofacial rhabdomyosarcoma in neonates and young children: a review of literature and management of four cases. Oral Oncol.38(5), 508–515 (2002).
   Google Scholar
• Pappo AS, Meza JL, Donaldson SS et al. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV. J. Clin. Oncol.21(4), 638–645 (2003).
   Google Scholar
• Hosoi H, Teramukai S, Matsumoto Y et al. A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan. Int. J. Clin. Oncol.12(2), 137–145 (2007).
   PubMedGoogle Scholar
• Schouwenburg PF, Kupperman D, Bakker FP et al. New combined treatment of surgery, radiotherapy, and reconstruction in head and neck rhabdomyosarcoma in children: the AMORE protocol. Head Neck20(4), 283–292 (1998).
   Google Scholar
• Raney RB, Asmar L, Vassilopoulou-Sellin R et al. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: a descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and -III. IRS Group of the Children’s Cancer Group and the Pediatric Oncology Group. Med. Pediatr. Oncol.33(4), 362–371 (1999).
   Google Scholar
• Baldi A, Nicoletti G, Colella G, Pia Di Marino M, Persichetti P. Embryonal rhabdomyosarcoma of the tongue in old age. Oral Oncol.40(4), 450–452 (2004).
   Google Scholar
• Parham DM, Ellison DA. Rhabdomyosarcomas in adults and children: an update. Arch. Pathol. Lab. Med.130(10), 1454–1465 (2006).
   PubMed Web of Science ®Google Scholar
• Qualman SJ, Bowen J, Parham DM, Branton PA, Meyer WH. Protocol for the examination of specimens from patients (children and young adults) with rhabdomyosarcoma. Arch. Pathol. Lab. Med.127(10), 1290–1297 (2003).
   PubMed Web of Science ®Google Scholar
• Nascimento AF, Fletcher CD. Spindle cell rhabdomyosarcoma in adults. Am. J. Surg. Pathol.29(8), 1106–1113 (2005).
   PubMedGoogle Scholar
• Morotti RA, Nicol KK, Parham DM et al. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children’s Oncology Group experience. Am. J. Surg. Pathol.30(8), 962–968 (2006).
   PubMed Web of Science ®Google Scholar
• Parham DM. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod. Pathol.14(5), 506–514 (2001).
   PubMed Web of Science ®Google Scholar
• Meazza C, Ferrari A, Casanova M et al. Evolving treatment strategies for parameningeal rhabdomyosarcoma: the experience of the Istituto Nazionale Tumori of Milan. Head Neck27(1), 49–57 (2005).
   PubMedGoogle Scholar
• La Quaglia MP, Heller G, Ghavimi F et al. The effect of age at diagnosis on outcome in rhabdomyosarcoma. Cancer73(1), 109–117 (1994).
   PubMed Web of Science ®Google Scholar
• Hicks J, Flaitz C. Rhabdomyosarcoma of the head and neck in children. Oral Oncol.38(5), 450–459 (2002).
   PubMed Web of Science ®Google Scholar
• Heffner DK. Prognostic factors in head and neck rhabdomyosarcoma. Head Neck25(5), 416–417; author reply 417 (2003).
   Google Scholar
• Paulino AC, Simon JH, Zhen W, Wen BC. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int. J. Radiat. Oncol. Biol. Phys.48(5), 1489–1495 (2000).
   PubMed Web of Science ®Google Scholar
• Meza JL, Anderson J, Pappo AS, Meyer WH. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children’s Oncology Group. J. Clin. Oncol.24(24), 3844–3851 (2006).
   PubMed Web of Science ®Google Scholar
• Schuck A, Mattke AC, Schmidt B et al. Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary? J. Clin. Oncol.22(1), 143–149 (2004).
   PubMedGoogle Scholar
• Pawlik TM, Paulino AF, McGinn CJ et al. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer98(8), 1716–1726 (2003).
   PubMed Web of Science ®Google Scholar
• Abdullah BH, Yahya HI, Talabani NA, Alash NI, Mirza KB. Gingival and cutaneous angiosarcoma. J. Oral Pathol. Med.29(8), 410–412 (2000).
   Google Scholar
• Tabata M, Sugihara K, Matsui R et al. Angiosarcoma of the tongue: report of a case with immunohistochemical findings. J. Oral Pathol. Med.28(2), 92–95 (1999).
   Google Scholar
• Favia G, Lo Muzio L, Serpico R, Maiorano E. Angiosarcoma of the head and neck with intra-oral presentation. A clinico-pathological study of four cases. Oral Oncol.38(8), 757–762 (2002).
   Google Scholar
• Nelson BL, Thompson LDR. Sinonasal tract angiosarcoma: a clinicopathologic and immunophenotypic study of 10 cases with a review of the literature. Head Neck Pathol.1(1), 1–12 (2007).
   Google Scholar
• Nagano T, Yamada Y, Ikeda T et al. Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients. Cancer110(3), 648–651 (2007).
   PubMed Web of Science ®Google Scholar
• Koontz BF, Miles EF, Rubio MA et al. Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies. Head Neck30(2), 262–266 (2008).
   Google Scholar
• Allon I, Vered M, Dayan D. Liposarcoma of the tongue: clinico-pathologic correlations of a possible underdiagnosed entity. Oral Oncol.41(7), 657–665 (2005).
   Google Scholar
• Sobral AP, de Oliveira Lima DN, Cazal C et al. Myxoid liposarcoma of the lip: correlation of histological and cytological features and review of the literature. J. Oral Maxillofac. Surg.65(8), 1660–1664 (2007).
   Google Scholar
• Capodiferro S, Scully C, Maiorano E, Lo Muzio L, Favia G. Liposarcoma circumscriptum (lipoma-like) of the tongue: report of a case. Oral Dis.10(6), 398–400 (2004).
   Google Scholar
• Chandan VS, Fung EK, Woods CI, de la Roza G. Primary pleomorphic liposarcoma of the parotid gland: a case report and review of the literature. Am. J. Otolaryngol.25(6), 432–437 (2004).
   Google Scholar
• Nascimento AF, McMenamin ME, Fletcher CD. Liposarcomas/atypical lipomatous tumors of the oral cavity: a clinicopathologic study of 23 cases. Ann. Diagn. Pathol.6(2), 83–93 (2002).
   PubMedGoogle Scholar
• Nikitakis NG, Lopes MA, Pazoki AE, Ord RA, Sauk JJ. MDM2+/CDK4+/p53+ oral liposarcoma: case report and review of the literature. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.92(2), 194–201 (2001).
   PubMed Web of Science ®Google Scholar
• Drevelegas A, Pilavaki M, Chourmouzi D. Lipomatous tumors of soft tissue: MR appearance with histological correlation. Eur. J. Radiol.50(3), 257–267 (2004).
   Web of Science ®Google Scholar
• da Cunha IW, Kowalski LP, Soares FA. Dedifferentiated liposarcoma of the oral cavity with angiosarcomatous dedifferentiation. Virchows Arch.446(4), 456–459 (2005).
   Google Scholar
• Golledge J, Fisher C, Rhys-Evans PH. Head and neck liposarcoma. Cancer76(6), 1051–1058 (1995).
   PubMed Web of Science ®Google Scholar
• Jones RL, Fisher C, Al-Muderis O, Judson IR. Differential sensitivity of liposarcoma subtypes to chemotherapy. Eur. J. Cancer41(18), 2853–2860 (2005).
   PubMed Web of Science ®Google Scholar
• Chan WY, McHenry ID, Carter LM, Reall G, Wales CJ. Gingival liposarcoma: an unusual polyp. Br. J. Oral Maxillofac. Surg.46(2), 150–151 (2008).
   Google Scholar
• Bukawa H, Kawabata A, Murano A et al. Monophasic epithelial synovial sarcoma arising in the temporomandibular joint. Int. J. Oral Maxillofac. Surg.36(8), 762–765 (2007).
   Google Scholar
• Monzen Y, Hirai N, Nishisaka T, Hayashi K. MR imaging of synovial sarcoma arising from the floor of the mouth: a case report. Radiat. Med.19(1), 47–50 (2001).
   Google Scholar
• Lai V, Farrag TY, Cao D et al. Synovial sarcoma of the infratemporal fossa. Am. J. Otolaryngol.28(6), 444–447 (2007).
   Google Scholar
• Luo CW, Liu CJ, Chang KM. Synovial sarcoma of the temporomandibular joint area: report of a case. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.104(4), e62–65 (2007).
   Google Scholar
• Komis C, Lagogiannis GA, Faratzis G, Rapidis AD. Synovial sarcoma of the tongue: report of a case and review of the literature. J. Oral Maxillofac. Surg.66(1), 154–160 (2008).
   Google Scholar
• Tilakaratne WM. Synovial sarcoma of the mandible. J. Oral Pathol. Med.35(1), 61–63 (2006).
   Google Scholar
• Kawata R, Terada T, Takenaka H, Kurisu Y, Tsuji M. Primary synovial sarcoma arising in the parotid region diagnosed by fluorescence in situ hybridization. Auris Nasus Larynx (2008) (In Press).
   Google Scholar
• Olsen RJ, Lydiatt WM, Koepsell SA et al. C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck. Head Neck27(10), 883–892 (2005).
   PubMed Web of Science ®Google Scholar
• Cihak RA, Lydiatt WM, Lydiatt DD, Bridge JA. Synovial sarcoma of the head and neck: chromosomal translation (X;18) as a diagnostic aid. Head Neck19(6), 549–553 (1997).
   Google Scholar
• Guillou L, Benhattar J, Bonichon F et al. Histologic grade, but not SYT–SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J. Clin. Oncol.22(20), 4040–4050 (2004).
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang J, He X, Niu Y. Synovial sarcoma in the oral and maxillofacial region: report of 4 cases and review of the literature. J. Oral Maxillofac. Surg.66(1), 161–167 (2008).
   Google Scholar
• Meer S, Coleman H, Altini M. Oral synovial sarcoma: a report of 2 cases and a review of the literature. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.96(3), 306–315 (2003).
   PubMedGoogle Scholar
• Khademi B, Mohammadianpanah M, Ashraf MJ, Yeganeh F. Synovial sarcoma of the parapharyngeal space. Auris Nasus Larynx34(1), 125–129 (2007).
   Google Scholar
• Guadagnolo BA, Zagars GK, Ballo MT et al. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.69(4), 1173–1180 (2007).
   PubMed Web of Science ®Google Scholar
• Rangheard AS, Vanel D, Viala J et al. Synovial sarcomas of the head and neck: CT and MR imaging findings of eight patients. AJNR Am. J. Neuroradiol.22(5), 851–857 (2001).
   Google Scholar
• Paulino AC. Synovial sarcoma prognostic factors and patterns of failure. Am. J. Clin. Oncol.27(2), 122–127 (2004).
   Google Scholar
• Ishibe T, Nakayama T, Okamoto T et al. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Clin. Cancer Res.11(7), 2702–2712 (2005).
   PubMed Web of Science ®Google Scholar
• Tamborini E, Bonadiman L, Greco A et al. Expression of ligand-activated KIT and platelet-derived growth factor receptor β tyrosine kinase receptors in synovial sarcoma. Clin. Cancer Res.10(3), 938–943 (2004).
   PubMed Web of Science ®Google Scholar
• Harb WJ, Luna MA, Patel SR et al. Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension. Head Neck29(8), 731–740 (2007).
   Web of Science ®Google Scholar
• Laskin WB, Miettinen M. Epithelioid sarcoma: new insights based on an extended immunohistochemical analysis. Arch. Pathol. Lab. Med.127(9), 1161–1168 (2003).
   PubMedGoogle Scholar
• Jameson CF, Simpson MT, Towers JF. Primary epithelioid sarcoma of the hard palate. A case report. Int. J. Oral Maxillofac. Surg.19(4), 240–242 (1990).
   Google Scholar
• Baratti D, Pennacchioli E, Casali PG et al. Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution. Ann. Surg. Oncol.14(12), 3542–3551 (2007).
   PubMed Web of Science ®Google Scholar
• Feller L, Wood NH, Lemmer J. HIV-associated Kaposi sarcoma: pathogenic mechanisms. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.104(4), 521–529 (2007).
   PubMed Web of Science ®Google Scholar
• Triantos D, Horefti E, Paximadi E et al. Presence of human herpes virus-8 in saliva and non-lesional oral mucosa in HIV-infected and oncologic immunocompromised patients. Oral Microbiol. Immunol.19(3), 201–204 (2004).
   Google Scholar
• Nafar M, Einollahi B, Hemati K, Gholi FP, Firouzan A. Development of malignancy following living donor kidney transplantation. Transplant Proc.37(7), 3065–3067 (2005).
   Google Scholar
• Lager I, Altini M, Coleman H, Ali H. Oral Kaposi’s sarcoma: a clinicopathologic study from South Africa. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.96(6), 701–710 (2003).
   PubMedGoogle Scholar
• Jindal JR, Campbell BH, Ward TO, Almagro US. Kaposi’s sarcoma of the oral cavity in a non-AIDS patient: case report and review of the literature. Head Neck17(1), 64–68 (1995).
   Google Scholar
• Bottler T, Kuttenberger J, Hardt N, Oehen HP, Baltensperger M. Non-HIV-associated Kaposi’s sarcoma of the tongue. Case report and review of the literature. Int. J. Oral Maxillofac. Surg.36(12), 1218–1220 (2007).
   Google Scholar
• Reis-Filho JS, Souto-Moura C, Lopes JM. Classic Kaposi’s sarcoma of the tongue: case report with emphasis on the differential diagnosis. J. Oral Maxillofac. Surg.60(8), 951–954 (2002).
   Google Scholar
• Pantanowitz L, Dezube BJ. Advances in the pathobiology and treatment of Kaposi sarcoma. Curr. Opin. Oncol.16(5), 443–449 (2004).
   PubMed Web of Science ®Google Scholar
• Gorsky M, Epstein JB. A case series of acquired immunodeficiency syndrome patients with initial neoplastic diagnoses of intraoral Kaposi’s sarcoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.90(5), 612–617 (2000).
   Google Scholar
• Mra Z, Chien J. Kaposi’s sarcoma of the tongue. Otolaryngol. Head Neck Surg.123(1 Pt 1), 151 (2000).
   Google Scholar
• Noel KE, Mardirossian G, Schneider L. Primary intraosseous Kaposi’s sarcoma presenting as an asymptomatic periapical radiolucency: a case report. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.103(5), e65–e70 (2007).
   Google Scholar
• Pak F, Mwakigonja AR, Kokhaei P et al. Kaposi’s sarcoma herpesvirus load in biopsies of cutaneous and oral Kaposi’s sarcoma lesions. Eur. J. Cancer43(12), 1877–1882 (2007).
   PubMed Web of Science ®Google Scholar
• Ramirez-Amador V, Esquivel-Pedraza L, Lozada-Nur F et al. Intralesional vinblastine vs.3% sodium tetradecyl sulfate for the treatment of oral Kaposi’s sarcoma. A double blind, randomized clinical trial. Oral Oncol.38(5), 460–467 (2002).
   PubMedGoogle Scholar
• McCormick SU. Intralesional vinblastine injections for the treatment of oral Kaposi’s sarcoma: report of 10 patients with 2-year follow-up. J. Oral Maxillofac. Surg.54(5), 583–587; discussion 588–589 (1996).
   PubMedGoogle Scholar
• Hajdu SI. Peripheral nerve sheath tumors. Histogenesis, classification, and prognosis. Cancer72(12), 3549–3552 (1993).
   PubMedGoogle Scholar
• Carli M, Ferrari A, Mattke A et al. Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group. J. Clin. Oncol.23(33), 8422–8430 (2005).
   PubMed Web of Science ®Google Scholar
• Heffner DK, Gnepp DR. Sinonasal fibrosarcomas, malignant schwannomas, and “Triton” tumors. A clinicopathologic study of 67 cases. Cancer70(5), 1089–1101 (1992).
   Google Scholar
• Ozer E, Erkilic S, Bayazit YA et al. Malignant triton tumor of the supraclavicular region arising after radiotherapy. Auris Nasus Larynx29(4), 405–407 (2002).
   Google Scholar
• Sorensen KB, Godballe C, Krogdahl A. Malignant triton tumor (MTT) of the neck. Auris Nasus Larynx33(1), 89–91 (2006).
   Google Scholar
• James JA, Bali NS, Sloan P, Shanks JH. Low-grade malignant Triton tumor of the oral cavity: a case report. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.95(6), 699–704 (2003).
   Google Scholar
• Velagaleti GV, Miettinen M, Gatalica Z. Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation (malignant triton tumor) with balanced t(7;9)(q11.2;p24) and unbalanced translocation der(16)t(1;16)(q23;q13). Cancer Genet. Cytogenet.149(1), 23–27 (2004).
   Google Scholar
• Kim ST, Kim CW, Han GC et al. Malignant triton tumor of the nasal cavity. Head Neck23(12), 1075–1078 (2001).
   Google Scholar
• Lang-Lazdunski L, Pons F, Jancovici R. Malignant “Triton” tumor of the posterior mediastinum: prolonged survival after staged resection. Ann. Thorac. Surg.75(5), 1645–1648 (2003).
   Google Scholar
• Vandeweyer E, Seyeidi JV, Deraemaecker R. Dermatofibrosarcoma protuberans of the upper lip: an overview and a case report. Eur. J. Surg. Oncol.23(3), 275–277 (1997).
   Google Scholar
• McArthur G. Dermatofibrosarcoma protuberans: recent clinical progress. Ann. Surg. Oncol.14(10), 2876–2886 (2007).
   PubMed Web of Science ®Google Scholar
• Stojadinovic A, Karpoff HM, Antonescu CR et al. Dermatofibrosarcoma protuberans of the head and neck. Ann. Surg. Oncol.7(9), 696–704 (2000).
   PubMed Web of Science ®Google Scholar
• Fiore M, Miceli R, Mussi C et al. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J. Clin. Oncol.23(30), 7669–7675 (2005).
   PubMed Web of Science ®Google Scholar
• Tom WD, Hybarger CP, Rasgon BM. Dermatofibrosarcoma protuberans of the head and neck: treatment with Mohs surgery using inverted horizontal paraffin sections. Laryngoscope113(8), 1289–1293 (2003).
   PubMed Web of Science ®Google Scholar
• Chang CK, Jacobs IA, Salti GI. Outcomes of surgery for dermatofibrosarcoma protuberans. Eur. J. Surg. Oncol.30(3), 341–345 (2004).
   PubMed Web of Science ®Google Scholar
• Portera CA Jr, Ho V, Patel SR et al. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer91(3), 585–591 (2001).
   PubMed Web of Science ®Google Scholar
• Kanhere HA, Pai PS, Neeli SI et al. Alveolar soft part sarcoma of the head and neck. Int. J. Oral Maxillofac. Surg.34(3), 268–272 (2005).
   Google Scholar
• Charrier JB, Esnault O, Brette MD, Monteil JP. Alveolar soft-part sarcoma of the cheek. Br. J. Oral Maxillofac. Surg.39(5), 394–397 (2001).
   Google Scholar
• Zarrin-Khameh N, Kaye KS. Alveolar soft part sarcoma. Arch. Pathol. Lab. Med.131(3), 488–491 (2007).
   PubMed Web of Science ®Google Scholar
• Bentley RP, Wake MJ, Raafat F. Alveolar soft part sarcoma of the tongue. Br. J. Oral Maxillofac. Surg.37(6), 451–454 (1999).
   Google Scholar
• Takita MA, Morishita M, Iriki-In M et al. Alveolar soft-part sarcoma of the tongue. Report of a case. Int. J. Oral Maxillofac. Surg.19(2), 110–112 (1990).
   Google Scholar
• Kimi K, Onodera K, Kumamoto H et al. Alveolar soft-part sarcoma of the cheek: report of a case with a review of the literature. Int. J. Oral Maxillofac. Surg.29(5), 366–369 (2000).
   Google Scholar
• do Nascimento Souza KC, Faria PR, Costa IM, Duriguetto AF Jr, Loyola AM. Oral alveolar soft-part sarcoma: review of literature and case report with immunohistochemistry study for prognostic markers. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.99(1), 64–70 (2005).
   Google Scholar
• Yoshida K, Kurauchi J, Shirasawa H, Kosugi I. Alveolar soft part sarcoma of the tongue. Report of a case. Int. J. Oral Maxillofac. Surg.29(5), 370–372 (2000).
   Google Scholar
• Aiken AH, Stone JA. Alveolar soft-part sarcoma of the tongue. AJNR Am. J. Neuroradiol.24(6), 1156–1158 (2003).
   Google Scholar
• Chow WA. Update on chondrosarcomas. Curr. Opin. Oncol.19(4), 371–376 (2007).
   PubMedGoogle Scholar
• Collins MS, Koyama T, Swee RG, Inwards CY. Clear cell chondrosarcoma: radiographic, computed tomographic, and magnetic resonance findings in 34 patients with pathologic correlation. Skeletal Radiol.32(12), 687–694 (2003).
   PubMedGoogle Scholar
• Zakkak TB, Flynn TR, Boguslaw B, Adamo AK. Mesenchymal chondrosarcoma of the mandible: case report and review of the literature. J. Oral Maxillofac. Surg.56(1), 84–91 (1998).
   Google Scholar
• Murayama S, Suzuki I, Nagase M et al. Chondrosarcoma of the mandible. Report of case and a survey of 23 cases in the Japanese literature. J. Craniomaxillofac. Surg.16(6), 287–292 (1988).
   Google Scholar
• Oghalai JS, Buxbaum JL, Jackler RK, McDermott MW. Skull base chondrosarcoma originating from the petroclival junction. Otol. Neurotol.26(5), 1052–1060 (2005).
   PubMed Web of Science ®Google Scholar
• Aigner T, Oliveira AM, Nascimento AG. Extraskeletal myxoid chondrosarcomas do not show a chondrocytic phenotype. Mod. Pathol.17(2), 214–221 (2004).
   PubMedGoogle Scholar
• Gorsky M, Epstein JB. Craniofacial osseous and chondromatous sarcomas in British Columbia – a review of 34 cases. Oral Oncol.36(1), 27–31 (2000).
   Google Scholar
• Tien N, Chaisuparat R, Fernandes R et al. Mesenchymal chondrosarcoma of the maxilla: case report and literature review. J. Oral Maxillofac. Surg.65(6), 1260–1266 (2007).
   Google Scholar
• Koch BB, Karnell LH, Hoffman HT et al. National cancer database report on chondrosarcoma of the head and neck. Head Neck22(4), 408–425 (2000).
   PubMed Web of Science ®Google Scholar
• Hisaoka M, Hashimoto H. Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics. Pathol. Int.55(8), 453–463 (2005).
   PubMedGoogle Scholar
• Saito K, Unni KK, Wollan PC, Lund BA. Chondrosarcoma of the jaw and facial bones. Cancer76(9), 1550–1558 (1995).
   PubMedGoogle Scholar
• Aziz SR, Miremadi AR, McCabe JC. Mesenchymal chondrosarcoma of the maxilla with diffuse metastasis: case report and literature review. J. Oral Maxillofac. Surg.60(8), 931–935 (2002).
   Google Scholar
• Rapidis AD, Archondakis G, Anteriotis D, Skouteris CA. Chondrosarcomas of the skull base: review of the literature and report of two cases. J. Craniomaxillofac. Surg.25(6), 322–327 (1997).
   PubMedGoogle Scholar
• Brenner W, Conrad EU, Eary JF. FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients. Eur. J. Nucl. Med. Mol. Imaging31(2), 189–195 (2004).
   PubMed Web of Science ®Google Scholar
• Kohanawa R, Tabuchi K, Okubo H, Nagata M, Hara A. Primary osteogenic sarcoma of the ethmoid sinus: a case report. Auris Nasus Larynx32(4), 411–413 (2005).
   Google Scholar
• Gorlick R, Anderson P, Andrulis I et al. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin. Cancer Res.9(15), 5442–5453 (2003).
   PubMed Web of Science ®Google Scholar
• Gleich LL, Eberle RC, Shaha AR, Solomon M. Paget’s sarcoma of the mandible. Head Neck17(5), 425–430 (1995).
   Google Scholar
• Garcia Garcia A, Barros F, Bouzas ML, Penaranda JM. Li-Fraumeni syndrome and osteosarcoma of the maxilla. J. Oral Maxillofac. Surg.56(9), 1106–1109 (1998).
   Google Scholar
• Gardner GM, Steiniger JR. Family cancer syndrome: a study of the kindred of a man with osteogenic sarcoma of the mandible. Laryngoscope100(12), 1259–1263 (1990).
   Google Scholar
• Patrikidou A, Bennett J, Abou-Sleiman P, Delhanty JD, Harris M. A novel, de novo germline TP53 mutation in a rare presentation of the Li-Fraumeni syndrome in the maxilla. Oral Oncol.38(4), 383–390 (2002).
   Google Scholar
• Kuhelj D, Jereb B. Pediatric osteosarcoma: a 35-year experience in Slovenia. Pediatr. Hematol. Oncol.22(4), 335–343 (2005).
   PubMed Web of Science ®Google Scholar
• Nakayama E, Sugiura K, Kobayashi I et al. The association between the computed tomography findings, histologic features, and outcome of osteosarcoma of the jaw. J. Oral Maxillofac. Surg.63(3), 311–318 (2005).
   Google Scholar
• Hewitt KM, Ellis G, Wiggins R, Bentz BG. Parosteal osteosarcoma: case report and review of the literature. Head Neck30(1), 122–126 (2008).
   Google Scholar
• dos Santos DT, Cavalcanti MG. Osteosarcoma of the temporomandibular joint: report of 2 cases. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.94(5), 641–647 (2002).
   PubMedGoogle Scholar
• Klein MJ, Siegal GP. Osteosarcoma: anatomic and histologic variants. Am. J. Clin. Pathol.125(4), 555–581 (2006).
   PubMed Web of Science ®Google Scholar
• Saito Y, Miyajima C, Nakao K, Asakage T, Sugasawa M. Highly malignant submandibular extraskeletal osteosarcoma in a young patient. Auris Nasus Larynx (2008) (Epub ahead of print).
   Google Scholar
• Oda D, Bavisotto LM, Schmidt RA et al. Head and neck osteosarcoma at the University of Washington. Head Neck19(6), 513–523 (1997).
   PubMedGoogle Scholar
• Ogunlewe MO, Ajayi OF, Adeyemo WL, Ladeinde AL, James O. Osteogenic sarcoma of the jaw bones: a single institution experience over a 21-year period. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.101(1), 76–81 (2006).
   Google Scholar
• Yoon JH, Yook JI, Kim HJ, Ho Cha I, Kim J. Periosteal osteosarcoma of the mandible. J. Oral Maxillofac. Surg.63(5), 699–703 (2005).
   Google Scholar
• Zorzan G, Tullio A, Bertolini F, Sesenna E. Osteosarcoma of the mandibular condyle: case report. J. Oral Maxillofac. Surg.59(5), 574–577 (2001).
   Google Scholar
• Mardinger O, Givol N, Talmi YP, Taicher S. Osteosarcoma of the jaw. The Chaim Sheba Medical Center experience. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.91(4), 445–451 (2001).
   Google Scholar
• Fernandes R, Nikitakis NG, Pazoki A, Ord RA. Osteogenic sarcoma of the jaw: a 10-year experience. J. Oral Maxillofac. Surg.65(7), 1286–1291 (2007).
   Google Scholar
• Isenberg SF, Dorwart RH. Osteogenic sarcoma of the maxilla: preoperative magnetic resonance imaging and computed tomography analyses. Am. J. Otolaryngol.18(3), 206–209 (1997).
   Google Scholar
• Bennett JH, Thomas G, Evans AW, Speight PM. Osteosarcoma of the jaws: a 30-year retrospective review. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.90(3), 323–332 (2000).
   Google Scholar
• Goepfert H, Ballantyne AJ, Matalon V, McCarthy E. Osteogenic sarcoma of the mandible: surgical resection and prosthetic rehabilitation. Otolaryngol. Head Neck Surg.87(4), 417–419 (1979).
   Google Scholar
• Smeele LE, Kostense PJ, van der Waal I, Snow GB. Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J. Clin. Oncol.15(1), 363–367 (1997).
   PubMed Web of Science ®Google Scholar
• Patel SG, Meyers P, Huvos AG et al. Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer95(7), 1495–1503 (2002).
   Google Scholar
• van Es RJ, Keus RB, van der Waal I, Koole R, Vermey A. Osteosarcoma of the jaw bones. Long-term follow up of 48 cases. Int. J. Oral Maxillofac. Surg.26(3), 191–197 (1997).
   PubMed Web of Science ®Google Scholar
• Carlson ER, Panella T, Holmes JD. Sarcoma of mandible. J. Oral Maxillofac. Surg.62(1), 81–87 (2004).
   Google Scholar
• Nissanka EH, Amaratunge EA, Tilakaratne WM. Clinicopathological analysis of osteosarcoma of jaw bones. Oral Dis.13(1), 82–87 (2007).
   Google Scholar
• Carrle D, Bielack SS. Current strategies of chemotherapy in osteosarcoma. Int. Orthop.30(6), 445–451 (2006).
   PubMed Web of Science ®Google Scholar
• Uhl M, Saueressig U, van Buiren M et al. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging. Invest. Radiol.41(8), 618–623 (2006).
   PubMed Web of Science ®Google Scholar
• Lopes MA, Nikitakis NG, Ord RA, Sauk J Jr. Amplification and protein expression of chromosome 12q13–15 genes in osteosarcomas of the jaws. Oral Oncol.37(7), 566–571 (2001).
   Google Scholar
• Nakase M, Inui M, Okumura K et al.p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome. Mol. Cancer Ther.4(4), 625–631 (2005).
   PubMed Web of Science ®Google Scholar
• Jordan RC, Glenn L, Treseler PA, Regezi JA. Granulocytic sarcoma: case report with an unusual presentation and review of the literature. J. Oral Maxillofac. Surg.60(10), 1206–1211 (2002).
   Google Scholar
• Nayak DR, Balakrishnan R, Raj G et al. Granulocytic sarcoma of the head and neck: a case report. Am. J. Otolaryngol.22(1), 80–83 (2001).
   Google Scholar
• Tomas Carmona I, Cameselle Teijeiro J, Diz Dios P, Fernandez Feijoo J, Limeres Posse J. Intra-alveolar granulocytic sarcoma developing after tooth extraction. Oral Oncol.36(5), 491–494 (2000).
   Google Scholar
• Lee SS, Kim HK, Choi SC, Lee JI. Granulocytic sarcoma occurring in the maxillary gingiva demonstrated by magnetic resonance imaging. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.92(6), 689–693 (2001).
   Google Scholar
• Tong AC, Lam KY. Granulocytic sarcoma presenting as an ulcerative mucogingival lesion: report of a case and review of the literature. J. Oral Maxillofac. Surg.58(9), 1055–1058 (2000).
   Google Scholar
• Amin KS, Ehsan A, McGuff HS, Albright SC. Minimally differentiated acute myelogenous leukemia (AML-M0) granulocytic sarcoma presenting in the oral cavity. Oral Oncol.38(5), 516–519 (2002).
   PubMed Web of Science ®Google Scholar
• Xie Z, Zhang F, Song E et al. Intraoral granulocytic sarcoma presenting as multiple maxillary and mandibular masses: a case report and literature review. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.103(6), e44–e48 (2007).
   Google Scholar
• Srinivasan B, Ethunandan M, Anand R, Hussein K, Ilankovan V. Granulocytic sarcoma of the lips: report of an unusual case. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.105(1), e34–e36 (2008).
   Google Scholar
• Galati LT, Barnes EL, Myers EN. Dendritic cell sarcoma of the thyroid. Head Neck21(3), 273–275 (1999).
   PubMed Web of Science ®Google Scholar
• Clement P, Saint-Blancard P, Minvielle F, Le Page P, Kossowski M. Follicular dendritic cell sarcoma of the tonsil: a case report. Am. J. Otolaryngol.27(3), 207–210 (2006).
   PubMed Web of Science ®Google Scholar
• Satoh K, Hibi G, Yamamoto Y et al. Follicular dendritic cell tumor in the oro-pharyngeal region: report of a case and a review of the literature. Oral Oncol.39(4), 415–419 (2003).
   PubMed Web of Science ®Google Scholar
• Biddle DA, Ro JY, Yoon GS et al. Extranodal follicular dendritic cell sarcoma of the head and neck region: three new cases, with a review of the literature. Mod. Pathol.15(1), 50–58 (2002).
   PubMed Web of Science ®Google Scholar
• Desai S, Deshpande RB, Jambhekar N. Follicular dendritic cell tumor of the parapharyngeal region. Head Neck21(2), 164–167 (1999).
   PubMed Web of Science ®Google Scholar
• Martins MT, Witzel AL, Sugaya NN, Kowalski LP, de Araujo VC. Dendritic cell sarcoma of the oral cavity. Oral Oncol.40(3), 341–347 (2004).
   Google Scholar
• Nakashima T, Kuratomi Y, Shiratsuchi H et al. Follicular dendritic cell sarcoma of the neck; a case report and literature review. Auris Nasus Larynx29(4), 401–403 (2002).
   PubMed Web of Science ®Google Scholar
• Postovsky S, Daitzchman M, Elhasid R, Arush MW. Ewing’s sarcoma of the facial zygomatic area bones in a young child: a case presentation. Am. J. Otolaryngol.21(3), 213–215 (2000).
   Google Scholar
• Talesh KT, Motamedi MH, Jeihounian M. Ewing’s sarcoma of the mandibular condyle: report of a case. J. Oral Maxillofac. Surg.61(10), 1216–1219 (2003).
   Google Scholar
• Solomon LW, Frustino JL, Loree TR et al. Ewing sarcoma of the mandibular condyle: multidisciplinary management optimizes outcome. Head Neck30(3), 405–410 (2008).
   Google Scholar
• Gorospe L, Fernandez-Gil MA, Garcia-Raya P et al. Ewing’s sarcoma of the mandible: radiologic features with emphasis on magnetic resonance appearance. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.91(6), 728–734 (2001).
   Google Scholar
• Carpentieri DF, Qualman SJ, Bowen J et al. Protocol for the examination of specimens from pediatric and adult patients with osseous and extraosseous ewing sarcoma family of tumors, including peripheral primitive neuroectodermal tumor and Ewing sarcoma. Arch. Pathol. Lab. Med.129(7), 866–873 (2005).
   PubMedGoogle Scholar
• Infante-Cossio P, Gutierrez-Perez JL, Garcia-Perla A, Noguer-Mediavilla M, Gavilan-Carrasco F. Primary Ewing’s sarcoma of the maxilla and zygoma: report of a case. J. Oral Maxillofac. Surg.63(10), 1539–1542 (2005).
   Google Scholar
• Grier HE, Krailo MD, Tarbell NJ et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N. Engl. J. Med.348(8), 694–701 (2003).
   PubMed Web of Science ®Google Scholar
• Sluga M, Windhager R, Lang S et al. A long-term review of the treatment of patients with Ewing’s sarcoma in one institution. Eur. J. Surg. Oncol.27(6), 569–573 (2001).
   PubMedGoogle Scholar
• Wexler LH, Kacker A, Piro JD, Haddad J Jr, Close LG. Combined modality treatment of Ewing’s sarcoma of the maxilla. Head Neck25(2), 168–172 (2003).
   Google Scholar
• Fuchs B, Inwards CY, Janknecht R. Vascular endothelial growth factor expression is up-regulated by EWS–ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing’s sarcoma. Clin. Cancer Res.10(4), 1344–1353 (2004).
   PubMed Web of Science ®Google Scholar
• Dalal S, Berry AM, Cullinane CJ et al. Vascular endothelial growth factor: a therapeutic target for tumors of the Ewing’s sarcoma family. Clin. Cancer Res.11(6), 2364–2378 (2005).
   PubMed Web of Science ®Google Scholar
• Bacci G, Longhi A, Ferrari S et al. Pattern of relapse in 290 patients with nonmetastatic Ewing’s sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999. Eur. J. Surg. Oncol.32(9), 974–979 (2006).
   PubMed Web of Science ®Google Scholar
• Bregni RC, Taylor AM, Garcia AM. Ameloblastic fibrosarcoma of the mandible: report of two cases and review of the literature. J. Oral Pathol. Med.30(5), 316–320 (2001).
   Google Scholar
• Lee OJ, Kim HJ, Lee BK, Cho KJ. CD34 expressing ameloblastic fibrosarcoma arising in the maxilla: a new finding. J. Oral Pathol. Med.34(5), 318–320 (2005).
   Google Scholar
• Nogueira Tde O, Carvalho YR, Rosa LE, Dos Santos LM. Possible malignant transformation of an ameloblastic fibroma to ameloblastic fibrosarcoma: a case report. J. Oral Maxillofac. Surg.55(2), 180–182 (1997).
   Google Scholar
• Kunkel M, Ghalibafian M, Radner H et al. Ameloblastic fibrosarcoma or odontogenic carcinosarcoma: a matter of classification? Oral Oncol.40(4), 444–449 (2004).
   Google Scholar
• Batista de Paula AM, da Costa Neto JQ, da Silva Gusmao E, Guimaraes Santos FB, Gomez RS. Immunolocalization of the p53 protein in a case of ameloblastic fibrosarcoma. J. Oral Maxillofac. Surg.61(2), 256–258 (2003).
   Google Scholar
• Williams MD, Hanna EY, El-Naggar AK. Anaplastic ameloblastic fibrosarcoma arising from recurrent ameloblastic fibroma: restricted molecular abnormalities of certain genes to the malignant transformation. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.104(1), 72–75 (2007).
   Google Scholar
• Dallera P, Bertoni F, Marchetti C, Bacchini P, Campobassi A. Ameloblastic fibrosarcoma of the jaw: report of five cases. J. Craniomaxillofac. Surg.22(6), 349–354 (1994).
   Google Scholar
• Ron E. Cancer risks from medical radiation. Health Phys.85(1), 47–59 (2003).
   PubMed Web of Science ®Google Scholar
• Komdeur R, Hoekstra HJ, Molenaar WM et al. Clinicopathologic assessment of postradiation sarcomas: KIT as a potential treatment target. Clin. Cancer Res.9(8), 2926–2932 (2003).
   Google Scholar
• Agir H, Sen C, Muezzinoglu B, Isl E. Report of a radiation-induced leiomyosarcoma arising from the posterior neck. J. Craniofac. Surg.18(5), 1018–1020 (2007).
   Google Scholar
• Huang G, Medlam G, Lee J et al. Error in the delivery of radiation therapy: results of a quality assurance review. Int. J. Radiat. Oncol. Biol. Phys.61(5), 1590–1595 (2005).
   Google Scholar
• Harvey RT, Donald PJ, Weinstein GS. Osteogenic sarcoma of the maxillary alveolus occurring five years following the Chernobyl nuclear accident. Am. J. Otolaryngol.17(3), 210–214 (1996).
   Google Scholar
• Maghami EG, St-John M, Bhuta S, Abemayor E. Postirradiation sarcoma: a case report and current review. Am. J. Otolaryngol.26(1), 71–74 (2005).
   Google Scholar
• Narayana A, Cohen GN, Zaider M et al. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers – preliminary results. Brachytherapy6(2), 157–163 (2007).
   PubMed Web of Science ®Google Scholar
• Patel SG, See AC, Williamson PA, Archer DJ, Evans PH. Radiation induced sarcoma of the head and neck. Head Neck21(4), 346–354 (1999).
   Google Scholar
• King AD, Ahuja AT, Teo P, Tse GM, Kew J. Radiation induced sarcomas of the head and neck following radiotherapy for nasopharyngeal carcinoma. Clin. Radiol.55(9), 684–689 (2000).
   Google Scholar
• Chen YW, Tu HF, Wu TH et al. Sarcomas and sarcomatoid tumor after radiotherapy of oral squamous cell carcinoma: analysis of 4 cases. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.105(1), 65–71 (2008).
   Google Scholar
• MacDougall RH, Kerr GR, Duncan W. Incidence of sarcoma in patients treated with fast neutrons. Int. J. Radiat. Oncol. Biol. Phys.66(3), 842–844 (2006).
   Google Scholar
• Sedghizadeh PP, Angiero F, Allen CM et al. Post-irradiation leiomyosarcoma of the maxilla: report of a case in a patient with prior radiation treatment for retinoblastoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.97(6), 726–731 (2004).
   Google Scholar
• Bentz BG, Singh B, Woodruff J et al. Head and neck soft tissue sarcomas: a multivariate analysis of outcomes. Ann. Surg. Oncol.11(6), 619–628 (2004).
   PubMed Web of Science ®Google Scholar
• Patel SG, Shaha AR, Shah JP. Soft tissue sarcomas of the head and neck: an update. Am. J. Otolaryngol.22(1), 2–18 (2001).
   Google Scholar
• Colville RJ, Charlton F, Kelly CG, Nicoll JJ, McLean NR. Multidisciplinary management of head and neck sarcomas. Head Neck27(9), 814–824 (2005).
   Web of Science ®Google Scholar
• Gullane P, Kraus D, Weber R. Soft tissue sarcoma. Head Neck24(3), 296–300 (2002).
   Google Scholar
• Kawaguchi N, Ahmed AR, Matsumoto S, Manabe J, Matsushita Y. The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin. Orthop. Relat. Res.41(9), 165–172 (2004).
   Google Scholar
• Stojadinovic A, Leung DH, Hoos A et al. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann. Surg.235(3), 424–434 (2002).
   PubMed Web of Science ®Google Scholar
• Penel N, Van Haverbeke C, Lartigau E et al. Head and neck soft tissue sarcomas of adult: prognostic value of surgery in multimodal therapeutic approach. Oral Oncol.40(9), 890–897 (2004).
   Web of Science ®Google Scholar
• de Bree R, van der Valk P, Kuik DJ et al. Prognostic factors in adult soft tissue sarcomas of the head and neck: a single-centre experience. Oral Oncol.42(7), 703–709 (2006).
   Web of Science ®Google Scholar
• Patel SC, Silbergleit R, Talati SJ. Sarcomas of the head and neck. Top Magn. Reson. Imaging10(6), 362–375 (1999).
   Google Scholar
• Barker JL Jr, Paulino AC, Feeney S, McCulloch T, Hoffman H. Locoregional treatment for adult soft tissue sarcomas of the head and neck: an institutional review. Cancer J.9(1), 49–57 (2003).
   Google Scholar
• Stoeckle E, Gardet H, Coindre JM et al. Prospective evaluation of quality of surgery in soft tissue sarcoma. Eur. J. Surg. Oncol.32(10), 1242–1248 (2006).
   PubMed Web of Science ®Google Scholar
• Chen SA, Morris CG, Amdur RJ et al. Adult head and neck soft tissue sarcomas. Am. J. Clin. Oncol.28(3), 259–263 (2005).
   Web of Science ®Google Scholar
• Kowalski LP, San CI. Prognostic factors in head and neck soft tissue sarcomas: analysis of 128 cases. J. Surg. Oncol.56(2), 83–88 (1994).
   Google Scholar
• Zagars GK, Ballo MT, Pisters PW et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 225 patients. Cancer97(10), 2530–2543 (2003).
   PubMed Web of Science ®Google Scholar
• Ballo MT, Zagars GK, Cormier JN et al. Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int. J. Radiat. Oncol. Biol. Phys.58(5), 1461–1467 (2004).
   Google Scholar
• Hui AC, Ngan SY, Wong K, Powell G, Choong PF. Preoperative radiotherapy for soft tissue sarcoma: the Peter MacCallum Cancer Centre experience. Eur. J. Surg. Oncol.32(10), 1159–1164 (2006).
   PubMedGoogle Scholar
• MacCallum PL, Hartnick CJ. Sarcomas of the head and neck: update on management protocols. Curr. Opin. Otolaryngol. Head Neck Surg.9, 377–379 (2001).
   Google Scholar
• Pappo AS, Devidas M, Jenkins J et al. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. J. Clin. Oncol.23(18), 4031–4038 (2005).
   PubMed Web of Science ®Google Scholar
• Bramwell V, Rouesse J, Steward W et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma – reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J. Clin. Oncol.12(6), 1137–1149 (1994).
   PubMed Web of Science ®Google Scholar
• Bramwell VH. Adjuvant chemotherapy for adult soft tissue sarcoma: Is there a standard of care? J. Clin. Oncol.19(5), 1235–1237 (2001).
   PubMed Web of Science ®Google Scholar
• Yang JC, Chang AE, Baker AR et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J. Clin. Oncol.16(1), 197–203 (1998).
   PubMed Web of Science ®Google Scholar
• Tierney JF, Mosseri V, Stewart LA, Souhami RL, Parmar MK. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br. J. Cancer72(2), 469–475 (1995).
   PubMed Web of Science ®Google Scholar
• Kraybill WG, Harris J, Spiro IJ et al. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. J. Clin. Oncol.24(4), 619–625 (2006).
   PubMed Web of Science ®Google Scholar
• Le Cesne A, Blay JY, Judson I et al. Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group trial. J. Clin. Oncol.23(3), 576–584 (2005).
   PubMed Web of Science ®Google Scholar
• Yovine A, Riofrio M, Blay JY et al. Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients. J. Clin. Oncol.22(5), 890–899 (2004).
   PubMed Web of Science ®Google Scholar
• Sturgis EM, Potter BO. Sarcomas of the head and neck region. Curr. Opin. Oncol.15(3), 239–252 (2003).
   PubMed Web of Science ®Google Scholar
• Bramwell VH, Morris D, Ernst DS et al. Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma. Clin. Cancer Res.8(2), 383–393 (2002).
   PubMedGoogle Scholar
• Baird K, Davis S, Antonescu CR et al. Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res, 65(20), 9226–9235 (2005).
   PubMed Web of Science ®Google Scholar
• Khan J, Wei JS, Ringner M et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med.7(6), 673–679 (2001).
   PubMed Web of Science ®Google Scholar
• Krause DS, Van Etten RA. Tyrosine kinases as targets for cancer therapy. N. Engl. J. Med.353(2), 172–187 (2005).
   PubMed Web of Science ®Google Scholar
• Tomlinson J, Barsky SH, Nelson S et al. Different patterns of angiogenesis in sarcomas and carcinomas. Clin. Cancer Res.5(11), 3516–3522 (1999).
   PubMed Web of Science ®Google Scholar
• Hoffman HT, Robinson RA, Spiess JL, Buatti J. Update in management of head and neck sarcoma. Curr. Opin. Oncol.16(4), 333–341 (2004).
   Google Scholar
• Heymach JV, Desai J, Manola J et al. Phase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomas. Clin. Cancer Res.10(17), 5732–5740 (2004).
   PubMed Web of Science ®Google Scholar
• Tschoep K, Kohlmann A, Schlemmer M, Haferlach T, Issels RD. Gene expression profiling in sarcomas. Crit. Rev. Oncol. Hematol.63(2), 111–124 (2007).
   PubMed Web of Science ®Google Scholar